Johnson & Johnson
3rd-quarter adjusted earnings topped analysts’ estimates but the health care large cut its revenue guidance for the year.
Johnson & Johnson
(ticker: JNJ) posted altered earnings of $2.55 a share on revenue of $23.8 billion.
Johnson & Johnson
3rd-quarter adjusted earnings topped analysts’ estimates but the health care large cut its revenue guidance for the year.
Johnson & Johnson
(ticker: JNJ) posted altered earnings of $2.55 a share on revenue of $23.8 billion.